Müller, Ulf J.

Nucleus Accumbens deep brain stimulation for alcohol addiction – safety and clinical long-term results of a pilot trial

Müller, U., Sturm, V., Voges, J., Heinze, H.-J., Galazky, I., Büntjen, L., Heldmann, M., Frodl, T., Steiner, J., & Bogerts, B. (2016) · Pharmacopsychiatry

Deep Brain Stimulation and Movement DisordersObsessive-Compulsive Spectrum Disorders

Cited by 108

Deep brain stimulation of the nucleus accumbens in treatment-resistant alcohol use disorder: A double-blind randomized controlled multi-center trial

Bach, P., Luderer, M., Müller, U. J., Jakobs, M., Baldermann, J. C., Voges, J., Kiening, K., Lux, A., Visser-Vandewalle, V., the DeBraSTRA study group, et al. (2023) · Translational Psychiatry

Deep Brain Stimulation and Movement DisordersSubstance Abuse Treatment and Outcomes

Cited by 65

Reduced microglial immunoreactivity for endogenous NMDA receptor agonist quinolinic acid in the hippocampus of schizophrenia patients

Gos, T., Myint, A.-M., Schiltz, K., Meyer-Lotz, G., Dobrowolny, H., Busse, S., Müller, U. J., Mawrin, C., Bernstein, H.-G., Bogerts, B., et al. (2014) · Brain, Behavior, and Immunity

Tryptophan and brain disordersNeuroinflammation and Neurodegeneration Mechanisms

Cited by 49

Decrease of serum S100B during an oral glucose tolerance test correlates inversely with the insulin response

Steiner, J., Bernstein, H.-G., Schiltz, K., Haase, T., Meyer-Lotz, G., Dobrowolny, H., Müller, U. J., Martins-de-Souza, D., Borucki, K., Schroeter, M. L., et al. (2014) · Psychoneuroendocrinology

S100 Proteins and AnnexinsAdipokines, Inflammation, and Metabolic Diseases

Cited by 13